Previously, we found that MYBMIM can suppress MYB:CBP/P300-dependent gene expression, leading to AML cell apoptosis that required MYB-mediated suppression of BCL2 (Ramaswamy et al., 2018). Here, CREBBP is linked to acute myeloid leukemia.